NFKB1 and lymphoma: Additionally, miR-17~92-driven lymphoma cells exhibited constitutive activation of PI3K due to PTEN and PHLPP2 repression, and of the NF-κB pathway, due to inhibition of NF-kB deubiquitinases, CYLD, and A20 [31].